Duopharma Biotech Berhad (KLSE:DPHARMA)
1.280
-0.020 (-1.54%)
At close: Aug 28, 2026
Duopharma Biotech Berhad Market Cap
Duopharma Biotech Berhad has a market cap or net worth of 1.23 billion as of August 31, 2026. Its market cap has decreased by -6.57% in one year.
Market Cap
1.23B
Enterprise Value
1.45B
Revenue
929.41M
Ranking
n/a
PE Ratio
12.05
Stock Price
1.28
ChartMarket Cap Chart
Since August 27, 2002, Duopharma Biotech Berhad's market cap has increased from 187.00M to 1.23B, an increase of 558.45%. That is a compound annual growth rate of 8.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 1.23B | 2.40% |
| Dec 31, 2025 | 1.20B | - |
| Dec 31, 2024 | 1.20B | -0.79% |
| Dec 29, 2023 | 1.21B | -20.94% |
| Dec 30, 2022 | 1.53B | -3.10% |
| Dec 31, 2021 | 1.58B | -33.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DXN Holdings Bhd. | 2.28B |
| Kotra Industries Berhad | 563.59M |
| Y.S.P. Southeast Asia Holding Berhad | 285.11M |
| Sunzen Group Berhad | 178.63M |
| Rhone Ma Holdings Berhad | 151.59M |
| Nova Wellness Group Berhad | 121.11M |
| PeterLabs Holdings Berhad | 63.30M |
| Bioalpha Holdings Berhad | 14.20M |